XT
VRCA icon

XTX Topco’s Verrica Pharmaceuticals VRCA Stock Holding History

XTX Topco’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,662
Closed -$122K – 4440
2025
Q4 		$122K Buy
+14,662
New +$81.2K ﹤0.01% 2583
2025
Q3 		– Sell
-1,106
Closed -$5.86K – 3341
2025
Q2 		$5.86K Sell
1,106
-4,604
-81% -$24.8K ﹤0.01% 2252
2025
Q1 		$25.3K Buy
5,710
+902
+19% +$5.83K ﹤0.01% 2103
2024
Q4 		$33.7K Sell
4,808
-18,307
-79% -$201K ﹤0.01% 1963
2024
Q3 		$335K Buy
+23,115
New +$1.04M 0.02% 1113
2023
Q2 		– Sell
-2,262
Closed -$147K – 1885
2023
Q1 		$147K Buy
+2,262
New +$137K 0.03% 1030
2022
Q3 		– Sell
-2,580
Closed -$50K – 1411
2022
Q2 		$50K Buy
+2,580
New +$130K 0.02% 743

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's VRCA Position: Q1 2026 in Review

XTX Topco sold out of Verrica Pharmaceuticals (VRCA) in Q1 2026, closing a stake of 14,662 shares — an estimated $122K sold.

XTX Topco first reported a position in VRCA in Q2 2022 and held it in 7 quarters. The position peaked at $335K in Q3 2024. 39 funds tracked by Wall St. Rank hold VRCA as of Q1 2026.

  • XTX Topco reported no remaining Verrica Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 14,662 Verrica Pharmaceuticals shares in Q1 2026, an estimated $122K.
  • XTX Topco first reported a position in Verrica Pharmaceuticals in Q2 2022 and held it in 7 quarters.
  • XTX Topco's Verrica Pharmaceuticals position peaked at $335K in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.